{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-402820","form_type":"8-K","ticker":"STOK","cik":"0001623526","company_name":"Stoke Therapeutics, Inc.","filed_at":"2026-09-25T20:05:49+00:00","discovered_at":"2026-09-25T20:07:12.042215+00:00","generated_at":"2026-10-12T13:21:54.015914+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Stoke Therapeutics director Edward Kaye resigns; board appoints Alexander Cumbo to Class III seat","bullets":["Edward M. Kaye, M.D. resigned as a Class III director and Research and Development Committee member effective Sept. 23, 2026; resignation was not due to any disagreement with Stoke Therapeutics.","The board appointed Alexander (Bo) Cumbo as a Class III director effective Sept. 23, 2026, to fill Kaye's vacancy; his term expires at the 2028 annual stockholders meeting.","Cumbo is independent under SEC and Nasdaq rules and has no Item 404(a) related-party transactions with Stoke; he entered Stoke's standard director indemnity agreement.","Under Stoke's non-employee director compensation program, Cumbo receives a $45,000 annual cash retainer and an initial option for 39,674 shares with a target grant date fair value of about $724,000.","The option vests in twelve substantially equal quarterly installments on each quarterly anniversary of the grant date."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-402820","json":"https://secwatch.observer/filing/0001193125-26-402820.json","markdown":"https://secwatch.observer/filing/0001193125-26-402820.md","text":"https://secwatch.observer/filing/0001193125-26-402820.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1623526/000119312526402820/0001193125-26-402820-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1623526/000119312526402820/d136438d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:21:54.015914+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}